Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-061016
Filing Date
2020-05-13
Accepted
2020-05-13 19:26:00
Documents
1
Period of Report
2018-03-07

Document Format Files

Seq Description Document Type Size
1 3/A a3a.html 3/A  
1 3/A a3a.xml 3/A 3445
  Complete submission text file 0001104659-20-061016.txt   4784
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Mehta Vimal (Reporting) CIK: 0001733369 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38410 | Film No.: 20874902